US20110281256A1 - Systems and Methods of Detecting and Demonstrating Hair Damage Via Evaluation of Protein Fragments - Google Patents
Systems and Methods of Detecting and Demonstrating Hair Damage Via Evaluation of Protein Fragments Download PDFInfo
- Publication number
- US20110281256A1 US20110281256A1 US13/109,546 US201113109546A US2011281256A1 US 20110281256 A1 US20110281256 A1 US 20110281256A1 US 201113109546 A US201113109546 A US 201113109546A US 2011281256 A1 US2011281256 A1 US 2011281256A1
- Authority
- US
- United States
- Prior art keywords
- hair
- sample
- protein
- maldi
- protein fragments
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 0 *C(NC(=O)C(C)=O)C(=O)C(C)C.*C(NC([H])=O)C(=O)C(C)C Chemical compound *C(NC(=O)C(C)=O)C(=O)C(C)C.*C(NC([H])=O)C(=O)C(C)C 0.000 description 2
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/4833—Physical analysis of biological material of solid biological material, e.g. tissue samples, cell cultures
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6827—Total protein determination, e.g. albumin in urine
- G01N33/6839—Total protein determination, e.g. albumin in urine involving dyes, e.g. Coomassie blue, bromcresol green
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
- G01N33/6851—Methods of protein analysis involving laser desorption ionisation mass spectrometry
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01J—ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
- H01J49/00—Particle spectrometers or separator tubes
- H01J49/0027—Methods for using particle spectrometers
- H01J49/0036—Step by step routines describing the handling of the data generated during a measurement
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4742—Keratin; Cytokeratin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6818—Sequencing of polypeptides
- G01N33/6824—Sequencing of polypeptides involving N-terminal degradation, e.g. Edman degradation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
Definitions
- Embodiments of the present disclosure are directed to a process for measuring the damage to the hair by the evaluation and identification of extracted protein fragments.
- Protein loss may be caused by everyday occurrences and environmental factors such as UV ray exposure, bleaching, coloring, perming, straightening, mechanical manipulation, and salt water contact.
- Proper hair architecture at the molecular level is an important characteristic of hair that has a healthy look, shine and feel.
- the hair comprises mostly protein and is not regenerative after it exits the scalp. Therefore, it is valuable to have products which protect the overall protein integrity of the hair. Thus, protection of the hair shaft on the protein and fiber level is important to ensure hair has a healthy look.
- Identifying the protein fragments extracted from the hair and correlating the type of protein fragment with a type of hair damage 1) enables a correct identification of the type of damage to the hair, and 2) may provide the information necessary to design products which either prevent the damage, or in the case of bleaches and/or other composition do not generate the damage. Additionally, it is also valuable to identify particular types of hair disease. Hair of individuals with hair diseases, do not react to damage and/or treatments in the same way as normal hair. Therefore, it may be possible to indicate what type of hair disease is present based upon the response of the hair at a protein level to a particular type of damage.
- the present disclosure relates generally to systems and methods for detecting types of hair damage by correlating protein fragments extracted from the hair to a type of hair damage.
- a method of correlating hair damage type or source to marker protein fragments comprising: generating two identical hair samples; sample A and sample B; applying a damaging composition or treatment to sample A; apply no damaging composition or treatment to sample B; extracting the labile proteins using a suitable solvent samples from each of sample A and sample B; analyzing the protein fragment samples from sample A and sample B with MALDI-MS; comparing the MALDI-MS results from sample A and sample B; identifying the marker protein fragments by identifying the unique modification patterns which exist in sample A that do not exist in sample B.
- a method for demonstrating hair damage type or source comprising: extracting the labile proteins using a suitable solvent from a hair sample; analyzing the protein fragments sample with MALDI-MS; resulting in protein fragment results; and identifying the hair damage by comparing the protein fragments results to a list of marker protein fragments for particular damage.
- FIG. 1 This figure is the MALDI-MS results of marker protein fragments for hair damaged by bleach in comparison to the MALDI-MS results of protein fragments for undamaged hair.
- hair means keratinous fibers of the human or animal origin, such as hairs on the head or eyelashes.
- keratinous protein is understood to mean those proteins present in hair.
- protein fragments means the amino acids and larger proteins that are damaged and broken off the keratinous protein structure and held within the hair structure by electrostatic interactions, weak hydrogen bonding matrix proteins and lipids, or any other force that does not include incorporation in the keratinous protein structure.
- marker protein fragment means the protein fragment which has been correlated to a particular type of hair damage and/or damaging treatment.
- elutes means removing proteins from hair via contacting hair with an aqueous solution without the addition of any reduction or extraction agents, thereby yielding no modification of the keratinous protein structure and no breaking or reduction of chemical bonds present in the hair sample other than electrostatic interactions, weak hydrogen bonding matrix proteins and lipids, or any other force that does not include incorporation in the keratinous protein structure.
- “elutable” means protein fragments present in the hair sample that may be removed from the hair structure in an aqueous solution without the addition of any reduction or extraction agents. Furthermore, “elutable” means proteins that may be carried out of the hair structure in an aqueous solution consisting essentially of water without the breaking or reduction of chemical bonds present in the keratinous protein structure other than electrostatic interactions, weak hydrogen bonding matrix proteins and lipids, or any other force that does not include incorporation in the keratinous protein structure.
- a method for detecting and demonstrating hair damage by utilizing an aqueous solution to extract protein fragments from the hair without modifying the keratinous protein structure is described in Patent Application No. 61/345,321 filed on May 17, 2010.
- the protein fragments are analyzed. From the analysis of the protein fragments it is possible to identify the type of damage that has been done to the hair, in particular it is possible to determine the source of the damage to the hair.
- One such specific marker protein fragment includes those marker protein fragments generated when the hair is bleached.
- a hair sample can be tested, the protein fragments extracted, and the resulting protein fragments tested using an antibody based detection, and/or a mass spectrometry technique.
- the protein fragments are evaluated using the Matrix Assisted Laser Desorption Ionization (“MALDI”), also known as the MALDI-TOF Mass Spectrometry “MALDI-MS”.
- MALDI-MS Matrix Assisted Laser Desorption Ionization
- MALDI-MS can be used for the analysis of biomolecules such as peptides and proteins and large organic molecules such as polymers.
- the analyte is first co-crystallized with a UV absorbing matrix such as alpha-cyano-4-hydroxycinnamic acid (CHCA), then subjected to pulse laser (YAG or nitrogen laser) radiation.
- CHCA alpha-cyano-4-hydroxycinnamic acid
- MALDI-TOF a time-of-flight mass analyzer is used.
- MALDI-TOF Data can be acquired in MS mode to generate molecular weight information (e.g., a peptide) and in MS/MS mode (e.g., a peptide sequence/structure information).
- Typical MALDI mass spectrum acquisition takes less than a minute so it can be used for fast screening of molecular species in samples of interest. Changes and molecular makers can be detected by comparing the mass spectra acquired in samples treated under different conditions such as virgin hair vs. bleached hair.
- MALDI-MS can be performed either with or without enzymatic digestion of proteins.
- the protein fragment test results are then compared to a library of known marker protein fragments to identify what type of hair damage, and in some situations, what is the original source of damage to the hair i.e. bleach. This enables a “fingerprinting” of damage; meaning that if a hair sample is tested and the results include certain marker protein fragments, then the hair sample has been damaged by a particular source.
- Additional methods for evaluating the protein fragments include, but are not limited to, liquid chromatography-electrospray mass spectrometry, antibodies against the protein fragments could be generated and an ELISA assay could be developed.
- reagents available through Applied Biosystems, Carlsbad Calif. can be used to establish covalent amine linkage of an isobaric tag to each lysine side chain and free N-terminal group of a protein fragment. This allows for multiple samples to be run simultaneously through the MALDI MS. Running multiple samples through the MALDI MS simultaneously minimizes variations in the test data due to test variability.
- a library of these marker protein fragments can be generated by damaging swatches of hair with a variety of different compositions or treatments and then analyzing the resulting protein fragments in comparison with a similar swatch of hair which has not been damaged.
- Marker protein fragments can be identified by the MALDI-MS, as it is believed the same marker protein results will be found based upon the type of damage that the hair has experienced. This means that the marker protein fragment is indicative of a type or source of hair damage. Hair damages by bleach results in particular marker protein fragments, hair damaged by UV results in particular marker protein fragments etc.
- the additional peaks result form chemical modification at the amine termini of the fragments.
- the protein fragments that correspond to the characteristic peaks are sequenced (see Table 1). Letters used to denote the protein sequences refer to the one-letter amino acid code (i.e.
- E glutamic acid
- I isoleucine etc.
- Additional modifications to these proteins include oxidation at Methionine, cysteine, and tryptophan residues, and deamindation at asparagine and glutamine residues can also be detected.
- the protein fragments mapped to Keratin 31, suggesting that this protein is degraded upon bleaching of the hair shaft.
- this method can also be used to indicate whether an individual's hair has a normal response to treatments. For example if an individual has a particular hair disease, a hair sample from this individual may not generate the same marker protein fragment as would a person who has a “normal” response. A person with a hair disease may generate additional, less and/or even different marker protein fragments than would be indicated by a normal response.
- a library of hair disease responses could also be created similar to that of the marker protein fragments for damage as described above. Therefore, a test for this hair disease could include exposing an individual's hair to a particular damaging treatment and then identifying the hair disease by the marker protein fragments that are generated from the damaging treatment.
- the soluble and insoluble protein fragments are analyzed separately. Analyzing the soluble and insoluble protein fragments separately can result in higher sensitivity of protein fragment detection. Additionally, analyzing these protein fragments separately may further refine the determination of the location of the damage to the hair. To measure the soluble and insoluble protein fragments separately, after removal of the hair fibers the sample the in water can be centrifuged or the insoluble portion can be left to settle out from the soluble portion.
- a bleaching solution consisting of 2% ammonium hydroxide, 0.2% tetrasodium EDTA (pH adjusted to 10.3 with acetic acid), and 6% hydrogen peroxide was prepared. Hair tresses (brown and natural white) were submerged in the bleaching solution and placed in a 40° C. oven. At timepoints of 30 to 90 minutes, hair tresses were removed from the bleaching solution, washed under DI tap water for two minutes, and dried.
- the amount of overall protein damage sustained by the hair tresses as a result of the bleaching treatments was assessed by measuring total protein loss from the hair. Briefly, 0.2-0.3 g of hair from each tress was clipped into 2 inch segments and added to a glass scintillation vial. DI water was added at a ratio of 1.0 ml DI water to 0.1 g hair, and samples were subjected to physical agitation for 60 minutes at 2,500 rpm on a vortex platform. Water extracts were analyzed for total protein concentration using the Lowry protein quantification assay. Results are summarized in Table 2.
- the specific protein damage sustained by the hair tresses as a result of the bleaching treatments was determined by analyzing the water extracts described above by MALDI-TOF analysis.
- Water extracts were mixed (1:1) directly with a MALDI matrix solution (5 mg of a-Cyano-4-hydroxycinnamic acid (CHCA) dissolved in 1 ml of 80:20:0.1 acetonitrile: water: trifluoroacetic acid). About 1 ul each sample was spotted on the MALDI plate and analyzed by MALDI-TOF/TOF 4800 plus system (AB-Sciex).
- Protein markers for hair damage detected in the water extracts of bleached hair include peaks with m/z 994/1037, 1596/1639, 1204, 1278 etc. Note peak 1038 is the deamidated form of 1037 and delta mass is 43 Da among the peaks 994/1037 and 1596/1639, etc. Results are summarized in Table 1 for the markers 1037 and 1204.
- a bleached water extract were separated by a reversed phase HPLC (2 mm ⁇ 15 cm, Jupiter, C4, 300 A column, HP1100 system), fractions were collected manually and lyophilized. Each fraction was re-dissolved in 20 ul of 0.02% trifluoroacetic acid (TFA)/water solution, 1:1 mixed with the MALDI matrix, spotted on MALDI plate for MALDI-sequencing.
- TFA trifluoroacetic acid
- another water extract of bleach hair was dried under vacuum and re-dissolved in 50 mM NH4Ac buffer (pH 8).
- Hair tresses (General Population brown hair) were exposed to UV light for time points of up to 75 h in an Atlas Ci3000+Xenon Arc Fade-Ometer at an irradiance setting of 1.48 W/m 2 at 420 nm, a chamber temperature of 35° C., and 80% relative humidity.
- One hour of UV exposure under the these conditions is approximately equivalent to 7.5 hours of external sun exposure in Florida, according to calculations performed using an Outdoor to Xenon Radiant Energy Conversion program provided by the manufacturer (Atlas Material Testing Technology LLC).
- the amount of overall protein damage sustained by the hair tresses as a result of the UV exposure was assessed by measuring total protein loss from the hair. Briefly, 0.2-0.3 g of hair from each tress was clipped into 2 inch segments and added to a glass scintillation vial. DI water was added at a ratio of 1.0 ml DI water to 0.1 g hair, and samples were subjected to physical agitation for 60 minutes at 2,500 rpm on a vortex platform. Water extracts were analyzed for total protein concentration using the Lowry protein quantification assay. Results are summarized in Table 3.
- the specific protein damage sustained by the hair tresses as a result of the UV exposure was determined by analyzing the water extracts described above by MALDI-TOF analysis.
- Water extracts were mixed (1:1) directly with a MALDI matrix solution (5 mg of a-Cyano-4-hydroxycinnamic acid (CHCA) dissolved in 1 ml of 80:20:0.1 acetonitrile: water: trifluoroacetic acid). About 1 ul each sample was spotted on the MALDI plate and analyzed by MALDI-TOF/TOF 4800 plus system (AB-Sciex).
- a protein marker for hair damage from UV was detected in the water extracts with m/z 1278.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Optics & Photonics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Embodiments of a method for demonstrating type and/or source of hair damage comprises extracting protein fragments from a hair sample with an aqueous solution, testing the resulting protein fragments with the MALDI-MS test, and then either comparing the results between a damaged sample and an undamaged sample or comparing the results between a damaged sample and a list of known marker protein fragments to identify the type and/or source of the damage.
Description
- This application claims the benefit of U.S. Provisional Application No. 61/345,321 filed May 17, 2010 and U.S. Provisional Application No. 61/354,397 filed Jun. 14, 2010 and U.S. Provisional Application No. 61/389,469 filed Oct. 4, 2010.
- Embodiments of the present disclosure are directed to a process for measuring the damage to the hair by the evaluation and identification of extracted protein fragments.
- Hair damage through protein loss is a known problem; however, most people have no recognition of the amount of protein loss experienced by their hair, or their level of hair health in general. Protein loss may be caused by everyday occurrences and environmental factors such as UV ray exposure, bleaching, coloring, perming, straightening, mechanical manipulation, and salt water contact.
- Proper hair architecture at the molecular level is an important characteristic of hair that has a healthy look, shine and feel. The hair comprises mostly protein and is not regenerative after it exits the scalp. Therefore, it is valuable to have products which protect the overall protein integrity of the hair. Thus, protection of the hair shaft on the protein and fiber level is important to ensure hair has a healthy look.
- Identifying the protein fragments extracted from the hair and correlating the type of protein fragment with a type of hair damage 1) enables a correct identification of the type of damage to the hair, and 2) may provide the information necessary to design products which either prevent the damage, or in the case of bleaches and/or other composition do not generate the damage. Additionally, it is also valuable to identify particular types of hair disease. Hair of individuals with hair diseases, do not react to damage and/or treatments in the same way as normal hair. Therefore, it may be possible to indicate what type of hair disease is present based upon the response of the hair at a protein level to a particular type of damage.
- Also, as the protein fragment is identified, products which utilize the available bonds that result from the protein loss, in particular products specialized for specific damage types, can be produced.
- The present disclosure relates generally to systems and methods for detecting types of hair damage by correlating protein fragments extracted from the hair to a type of hair damage.
- A method of correlating hair damage type or source to marker protein fragments comprising: generating two identical hair samples; sample A and sample B; applying a damaging composition or treatment to sample A; apply no damaging composition or treatment to sample B; extracting the labile proteins using a suitable solvent samples from each of sample A and sample B; analyzing the protein fragment samples from sample A and sample B with MALDI-MS; comparing the MALDI-MS results from sample A and sample B; identifying the marker protein fragments by identifying the unique modification patterns which exist in sample A that do not exist in sample B.
- A method for demonstrating hair damage type or source, the method comprising: extracting the labile proteins using a suitable solvent from a hair sample; analyzing the protein fragments sample with MALDI-MS; resulting in protein fragment results; and identifying the hair damage by comparing the protein fragments results to a list of marker protein fragments for particular damage.
-
FIG. 1 . This figure is the MALDI-MS results of marker protein fragments for hair damaged by bleach in comparison to the MALDI-MS results of protein fragments for undamaged hair. - As used herein, “hair” means keratinous fibers of the human or animal origin, such as hairs on the head or eyelashes. Furthermore, as used herein, the term “keratinous protein” is understood to mean those proteins present in hair. As used herein, the term “protein fragments” means the amino acids and larger proteins that are damaged and broken off the keratinous protein structure and held within the hair structure by electrostatic interactions, weak hydrogen bonding matrix proteins and lipids, or any other force that does not include incorporation in the keratinous protein structure.
- As used herein “marker protein fragment” means the protein fragment which has been correlated to a particular type of hair damage and/or damaging treatment.
- As used herein, “elutes,” “eluting,” and the like means removing proteins from hair via contacting hair with an aqueous solution without the addition of any reduction or extraction agents, thereby yielding no modification of the keratinous protein structure and no breaking or reduction of chemical bonds present in the hair sample other than electrostatic interactions, weak hydrogen bonding matrix proteins and lipids, or any other force that does not include incorporation in the keratinous protein structure.
- As used herein, “elutable” means protein fragments present in the hair sample that may be removed from the hair structure in an aqueous solution without the addition of any reduction or extraction agents. Furthermore, “elutable” means proteins that may be carried out of the hair structure in an aqueous solution consisting essentially of water without the breaking or reduction of chemical bonds present in the keratinous protein structure other than electrostatic interactions, weak hydrogen bonding matrix proteins and lipids, or any other force that does not include incorporation in the keratinous protein structure.
- A method has been developed for detecting and demonstrating hair damage by utilizing an aqueous solution to extract protein fragments from the hair without modifying the keratinous protein structure. One such method is described in Patent Application No. 61/345,321 filed on May 17, 2010. Once the protein fragments are extracted from the hair, the protein fragments are analyzed. From the analysis of the protein fragments it is possible to identify the type of damage that has been done to the hair, in particular it is possible to determine the source of the damage to the hair. One such specific marker protein fragment includes those marker protein fragments generated when the hair is bleached. A hair sample can be tested, the protein fragments extracted, and the resulting protein fragments tested using an antibody based detection, and/or a mass spectrometry technique. In one embodiment the protein fragments are evaluated using the Matrix Assisted Laser Desorption Ionization (“MALDI”), also known as the MALDI-TOF Mass Spectrometry “MALDI-MS”. This technique is a soft ionization technique used in mass spectrometry. MALDI-MS can be used for the analysis of biomolecules such as peptides and proteins and large organic molecules such as polymers. In MALDI, the analyte is first co-crystallized with a UV absorbing matrix such as alpha-cyano-4-hydroxycinnamic acid (CHCA), then subjected to pulse laser (YAG or nitrogen laser) radiation. This causes the vaporization/desorption of the analyte/matrix crystals and produces ions which are transmitted into a mass analyzer for detection. In MALDI-TOF, a time-of-flight mass analyzer is used. MALDI-TOF Data can be acquired in MS mode to generate molecular weight information (e.g., a peptide) and in MS/MS mode (e.g., a peptide sequence/structure information). Typical MALDI mass spectrum acquisition takes less than a minute so it can be used for fast screening of molecular species in samples of interest. Changes and molecular makers can be detected by comparing the mass spectra acquired in samples treated under different conditions such as virgin hair vs. bleached hair.
- MALDI-MS can be performed either with or without enzymatic digestion of proteins. The protein fragment test results are then compared to a library of known marker protein fragments to identify what type of hair damage, and in some situations, what is the original source of damage to the hair i.e. bleach. This enables a “fingerprinting” of damage; meaning that if a hair sample is tested and the results include certain marker protein fragments, then the hair sample has been damaged by a particular source.
- Additional methods for evaluating the protein fragments include, but are not limited to, liquid chromatography-electrospray mass spectrometry, antibodies against the protein fragments could be generated and an ELISA assay could be developed.
- Further an iTRAQ method, reagents available through Applied Biosystems, Carlsbad Calif. can be used to establish covalent amine linkage of an isobaric tag to each lysine side chain and free N-terminal group of a protein fragment. This allows for multiple samples to be run simultaneously through the MALDI MS. Running multiple samples through the MALDI MS simultaneously minimizes variations in the test data due to test variability.
- A library of these marker protein fragments can be generated by damaging swatches of hair with a variety of different compositions or treatments and then analyzing the resulting protein fragments in comparison with a similar swatch of hair which has not been damaged. Marker protein fragments can be identified by the MALDI-MS, as it is believed the same marker protein results will be found based upon the type of damage that the hair has experienced. This means that the marker protein fragment is indicative of a type or source of hair damage. Hair damages by bleach results in particular marker protein fragments, hair damaged by UV results in particular marker protein fragments etc.
- It is believed that hair damaged by bleach results in +28 and +71 modification to the N-terminus of the protein fragment having the structure:
- For example as indicated in
FIG. 1 specific sets of fragments are released from bleached hair and extracted with water that are not present in an undamaged (virgin hair) sample. The sets of MS peaks consists of two unmodified protein peaks (966 and 1568) as well as peaks corresponding to Molecular Weights of unmodified protein peak plus 28 Daltons (966+28=994 and 1568+28=1596). The additional peaks result form chemical modification at the amine termini of the fragments. The protein fragments that correspond to the characteristic peaks are sequenced (see Table 1). Letters used to denote the protein sequences refer to the one-letter amino acid code (i.e. E=glutamic acid, I=isoleucine etc.) Additional modifications to these proteins include oxidation at Methionine, cysteine, and tryptophan residues, and deamindation at asparagine and glutamine residues can also be detected. The protein fragments mapped to Keratin 31, suggesting that this protein is degraded upon bleaching of the hair shaft. -
TABLE 1 Examples of protein damage markers in bleached hair Marker Ion (m/z) Protein Sequence Modification Protein ID 966 ---CNSFVR Unmodified Keratin 31 994 ---CNSFVR +28 Da @ N-terminus Keratin 31 1037 ---CNSFVR +71 Da @ N-terminus Keratin 31 1038 ---CNSFVR +71 Da @N-terminus, Keratin 31 Deamidated @ N 1308 EINTYRSLLE +71 Da @ N-terminus Keratin 31 1568 EINTYRSLLESED Unmodified Keratin 31 1596 EINTYRSLLESED +28 Da @ N-terminus Keratin 31 1639 EINTYRSLLESED +71 Da @ N-terminus Keratin 31 1204 FCEGSFNGSEK Unmodified Keratin 31 1205 FCEGSFNGSEK Asparagine (N) @ 7 Keratin 31 deamidated - Additionally, this method can also be used to indicate whether an individual's hair has a normal response to treatments. For example if an individual has a particular hair disease, a hair sample from this individual may not generate the same marker protein fragment as would a person who has a “normal” response. A person with a hair disease may generate additional, less and/or even different marker protein fragments than would be indicated by a normal response. A library of hair disease responses could also be created similar to that of the marker protein fragments for damage as described above. Therefore, a test for this hair disease could include exposing an individual's hair to a particular damaging treatment and then identifying the hair disease by the marker protein fragments that are generated from the damaging treatment.
- In one embodiment of this hair protein loss test method the soluble and insoluble protein fragments are analyzed separately. Analyzing the soluble and insoluble protein fragments separately can result in higher sensitivity of protein fragment detection. Additionally, analyzing these protein fragments separately may further refine the determination of the location of the damage to the hair. To measure the soluble and insoluble protein fragments separately, after removal of the hair fibers the sample the in water can be centrifuged or the insoluble portion can be left to settle out from the soluble portion.
- Hair samples were bleached using the following protocols:
- A bleaching solution consisting of 2% ammonium hydroxide, 0.2% tetrasodium EDTA (pH adjusted to 10.3 with acetic acid), and 6% hydrogen peroxide was prepared. Hair tresses (brown and natural white) were submerged in the bleaching solution and placed in a 40° C. oven. At timepoints of 30 to 90 minutes, hair tresses were removed from the bleaching solution, washed under DI tap water for two minutes, and dried.
- Identical to
Protocol # 1, with the exception that hydrogen peroxide (H202) was excluded from the bleaching solution. - Identical to
Protocol # 1, with the exception that tetrasodium EDTA (C10H12N2O8Na4) was excluded from the bleaching solution. - The amount of overall protein damage sustained by the hair tresses as a result of the bleaching treatments was assessed by measuring total protein loss from the hair. Briefly, 0.2-0.3 g of hair from each tress was clipped into 2 inch segments and added to a glass scintillation vial. DI water was added at a ratio of 1.0 ml DI water to 0.1 g hair, and samples were subjected to physical agitation for 60 minutes at 2,500 rpm on a vortex platform. Water extracts were analyzed for total protein concentration using the Lowry protein quantification assay. Results are summarized in Table 2.
- The specific protein damage sustained by the hair tresses as a result of the bleaching treatments was determined by analyzing the water extracts described above by MALDI-TOF analysis. Water extracts were mixed (1:1) directly with a MALDI matrix solution (5 mg of a-Cyano-4-hydroxycinnamic acid (CHCA) dissolved in 1 ml of 80:20:0.1 acetonitrile: water: trifluoroacetic acid). About 1 ul each sample was spotted on the MALDI plate and analyzed by MALDI-TOF/TOF 4800 plus system (AB-Sciex). Protein markers for hair damage detected in the water extracts of bleached hair include peaks with m/z 994/1037, 1596/1639, 1204, 1278 etc. Note peak 1038 is the deamidated form of 1037 and delta mass is 43 Da among the peaks 994/1037 and 1596/1639, etc. Results are summarized in Table 1 for the markers 1037 and 1204.
- To identify and sequence of marker proteins observed in MALDI-TOF analysis, a bleached water extract were separated by a reversed phase HPLC (2 mm×15 cm, Jupiter, C4, 300 A column, HP1100 system), fractions were collected manually and lyophilized. Each fraction was re-dissolved in 20 ul of 0.02% trifluoroacetic acid (TFA)/water solution, 1:1 mixed with the MALDI matrix, spotted on MALDI plate for MALDI-sequencing. For a more complete identification of proteins/proteins in the water extracts in addition those damage markers, another water extract of bleach hair was dried under vacuum and re-dissolved in 50 mM NH4Ac buffer (pH 8). 10 ul of trypsin (0.25 ug/u1 in water) was added to the buffer solution and incubated at 37 C for 4 hour. The tryptic digest was dried under vacuum and re-dissolved in 50 ul of 0.02& TFA/water, followed by HPLC separation. The LC fractions were collected, dried, and analyzed by MALDI-sequencing. MALDI raw data collected from both the non-tryptic and the tryptic LC fractions was searched against protein database using ProteinPilot software (AB-Sciex). The results are summarized below. Many different forms of hair keratins were detected in water extracts of the bleached hair after tryptic digestion. Keratins 81, 85, 31, 86, 33a, 33b, and 83 are among the major ones.
- Modifications, including oxidation at Met, Cys and Trp; deamidation at Asn and Gln; formylation (+28 da to unmodified sequence) and an unknown modification (+71 da, to be further determined) at N-terminal residues were detected.
- There are several pairs of proteins with delta mass 43 da, e.g., 994/1037 and 1596/1639 in the water extract and 1513/1556, 1954/1997, etc in the tryptic water extract of the bleached hair were observed. These pairs likely are the results of modifications with formylation (+28 Da) and an unknown formation (+71 Da) at N-terminal to proteins. The exact reaction chemistry of these possible modifications is unclear. These peaks and the pair (pattern) could be used as markers for hair damage.
-
TABLE 2 Protein Rx Bleaching Concentration Marker Marker Hair Type Time Protocol (μg/ml) 1037 1204 Natural White 50 min Protocol #3 8176.3 ug/ml x x Natural White 80 min Protocol #3 26505.1 ug/ml x Natural White 90 min Protocol #3 5849.3 ug/ml x x Brown 90 min Protocol #3 230.9 μg/ml Natural White 30 min Protocol # 1 876.0 ug/ml xxx xxx Natural White 60 min Protocol # 1 1079.0 ug/ml xxx xxx Natural White 90 min Protocol # 1 2322.8 ug/ml xx xx Brown 90 min Protocol # 1 1097.8 ug/ml x x Natural White 90 min Protocol #2 503.8 μg/ml x Brown 90 min Protocol #2 330.0 μg/ml x indicates that the marker is present Signal intensity xxx > xx > x - Damage to hair fibers upon exposure to UV light have been documented, including impairment of mechanical properties, morphological damage, and protein loss. The specific protein breakdown caused by UV to identify peptide markers for UV damage to the hair is examined via the process defined below.
- 1. Ultraviolet (UV) radiation exposure of Hair to Generate Marker Protein Fragments Which indicate Damage from UV:
- Protocol: Hair tresses (General Population brown hair) were exposed to UV light for time points of up to 75 h in an Atlas Ci3000+Xenon Arc Fade-Ometer at an irradiance setting of 1.48 W/m2 at 420 nm, a chamber temperature of 35° C., and 80% relative humidity. One hour of UV exposure under the these conditions is approximately equivalent to 7.5 hours of external sun exposure in Florida, according to calculations performed using an Outdoor to Xenon Radiant Energy Conversion program provided by the manufacturer (Atlas Material Testing Technology LLC).
- 2. Protein Loss Analysis of Hair Tresses Post-UV: (Note: this is the same protocol as used for bleached hair)
- The amount of overall protein damage sustained by the hair tresses as a result of the UV exposure was assessed by measuring total protein loss from the hair. Briefly, 0.2-0.3 g of hair from each tress was clipped into 2 inch segments and added to a glass scintillation vial. DI water was added at a ratio of 1.0 ml DI water to 0.1 g hair, and samples were subjected to physical agitation for 60 minutes at 2,500 rpm on a vortex platform. Water extracts were analyzed for total protein concentration using the Lowry protein quantification assay. Results are summarized in Table 3.
- 3. MALDI-TOF Analysis of Hair Tresses Post-UV:
- The specific protein damage sustained by the hair tresses as a result of the UV exposure was determined by analyzing the water extracts described above by MALDI-TOF analysis. Water extracts were mixed (1:1) directly with a MALDI matrix solution (5 mg of a-Cyano-4-hydroxycinnamic acid (CHCA) dissolved in 1 ml of 80:20:0.1 acetonitrile: water: trifluoroacetic acid). About 1 ul each sample was spotted on the MALDI plate and analyzed by MALDI-TOF/TOF 4800 plus system (AB-Sciex). A protein marker for hair damage from UV was detected in the water extracts with m/z 1278. While low levels of this marker were also detected in bleached hair extracts, this marker is more abundant after UV damage and is the predominant low molecular weight fragment found after UV insult to hair. This marker was also found to increase as a function of the amount of UV exposure to the hair within a consumer-relevant exposure range (Table 3).
-
TABLE 3 Approx. External Sun m/z 1278 intensity Hair Type Rx Time Exposure in Florida (mean of 2x samples) Brown No Treatment 0 h 157 Brown 5 h 38 h 819 Brown 10 h 75 h 1383 Brown 20 h 150 h 2347 Brown 30 h 225 h 2597 Brown 40 h 300 h 4906 Brown 50 h 375 h 2866 Brown 75 h 563 h 3354 - The dimensions and values disclosed herein are not to be understood as being strictly limited to the exact numerical values recited. Instead, unless otherwise specified, each such dimension is intended to mean both the recited value and a functionally equivalent range surrounding that value. For example, a dimension disclosed as “40 mm” is intended to mean “about 40 mm.”
- Every document cited herein, including any cross referenced or related patent or application, is hereby incorporated herein by reference in its entirety unless expressly excluded or otherwise limited. The citation of any document is not an admission that it is prior art with respect to any invention disclosed or claimed herein or that it alone, or in any combination with any other reference or references, teaches, suggests or discloses any such invention. Further, to the extent that any meaning or definition of a term in this document conflicts with any meaning or definition of the same term in a document incorporated by reference, the meaning or definition assigned to that term in this document shall govern.
- While particular embodiments of the present invention have been illustrated and described, it would be obvious to those skilled in the art that various other changes and modifications can be made without departing from the spirit and scope of the invention. It is therefore intended to cover in the appended claims all such changes and modifications that are within the scope of this invention.
Claims (5)
1. A method of correlating hair damage type or source to marker protein fragments comprising:
a) generating two identical hair samples; sample A and sample B;
b) applying a damaging composition or treatment to sample A; apply no damaging composition or treatment to sample B;
c) extracting the labile proteins using a suitable solvent samples from each of sample A and sample B;
d) analyzing the protein fragment samples from sample A and sample B with MALDI-MS;
e) comparing the MALDI-MS results from sample A and sample B;
f) identifying the marker protein fragments by identifying the unique modification patterns which exist in sample A that do not exist in sample B.
2. The method of claim 1 , wherein the MALDI-MS is performed after enzymatic digestion of proteins.
3. The method of claim 1 , wherein the MALDI-MS is performed without the enzymatic digestion of proteins.
4. A method for demonstrating hair damage type or source, the method comprising:
a) extracting the labile proteins using a suitable solvent from a hair sample;
b) analyzing the protein fragments sample with MALDI-MS; resulting in protein fragment results;
c) identifying the hair damage by comparing the protein fragments results to a list of marker protein fragments for particular damage.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/109,546 US20110281256A1 (en) | 2010-05-17 | 2011-05-17 | Systems and Methods of Detecting and Demonstrating Hair Damage Via Evaluation of Protein Fragments |
US14/217,977 US9310351B2 (en) | 2010-05-17 | 2014-03-18 | Systems and methods of detecting and demonstrating hair damage via evaluation of protein fragments |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US34532110P | 2010-05-17 | 2010-05-17 | |
US35439710P | 2010-06-14 | 2010-06-14 | |
US38946910P | 2010-10-04 | 2010-10-04 | |
US13/109,546 US20110281256A1 (en) | 2010-05-17 | 2011-05-17 | Systems and Methods of Detecting and Demonstrating Hair Damage Via Evaluation of Protein Fragments |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/217,977 Division US9310351B2 (en) | 2010-05-17 | 2014-03-18 | Systems and methods of detecting and demonstrating hair damage via evaluation of protein fragments |
Publications (1)
Publication Number | Publication Date |
---|---|
US20110281256A1 true US20110281256A1 (en) | 2011-11-17 |
Family
ID=44912104
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/109,546 Abandoned US20110281256A1 (en) | 2010-05-17 | 2011-05-17 | Systems and Methods of Detecting and Demonstrating Hair Damage Via Evaluation of Protein Fragments |
US14/217,977 Active 2031-05-27 US9310351B2 (en) | 2010-05-17 | 2014-03-18 | Systems and methods of detecting and demonstrating hair damage via evaluation of protein fragments |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/217,977 Active 2031-05-27 US9310351B2 (en) | 2010-05-17 | 2014-03-18 | Systems and methods of detecting and demonstrating hair damage via evaluation of protein fragments |
Country Status (6)
Country | Link |
---|---|
US (2) | US20110281256A1 (en) |
EP (1) | EP2572201B1 (en) |
JP (1) | JP5513679B2 (en) |
CN (1) | CN102893160B (en) |
CA (1) | CA2798517C (en) |
WO (1) | WO2011146462A1 (en) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20150364312A1 (en) * | 2014-06-12 | 2015-12-17 | The Procter & Gamble Company | Systems and Methods Of Detecting and Demonstrating Heat Damage to Hair Via Evaluation of Peptides |
US20150362507A1 (en) * | 2014-06-12 | 2015-12-17 | The Procter & Gamble Company | System and Methods of Detecting and Demonstrating Ultraviolet Damage to Hair Via Evaluation of Protein Fragments |
US9310351B2 (en) | 2010-05-17 | 2016-04-12 | The Procter & Gamble Company | Systems and methods of detecting and demonstrating hair damage via evaluation of protein fragments |
US9671410B2 (en) | 2011-01-16 | 2017-06-06 | The Procter & Gamble Company | Biomarker-based methods for identifying and formulating compositions that improve skin quality and reduce the visible signs of aging in skin |
US10966916B2 (en) | 2014-11-10 | 2021-04-06 | The Procter And Gamble Company | Personal care compositions |
US10987290B2 (en) | 2017-10-20 | 2021-04-27 | The Procter And Gamble Company | Aerosol foam skin cleanser |
CN113125546A (en) * | 2020-11-06 | 2021-07-16 | 郑州安图生物工程股份有限公司 | Hair mass spectrum detection chip and hair rapid identification method |
US11207261B2 (en) | 2014-11-10 | 2021-12-28 | The Procter And Gamble Company | Personal care compositions with two benefit phases |
US11207248B2 (en) | 2014-11-10 | 2021-12-28 | The Procter And Gamble Company | Personal care compositions with two benefit phases |
US11365397B2 (en) | 2018-11-29 | 2022-06-21 | The Procter & Gamble Company | Methods for screening personal care products |
US11419805B2 (en) | 2017-10-20 | 2022-08-23 | The Procter & Gamble Company | Aerosol foam skin cleanser |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6097636B2 (en) * | 2013-05-20 | 2017-03-15 | 一般社団法人日本真珠振興会 | Identification method of pearl nucleus |
DE102014016526A1 (en) * | 2014-10-30 | 2016-05-04 | Khs Corpoplast Gmbh | Device for pumping a liquid in a liquid line |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100099200A1 (en) * | 2007-03-16 | 2010-04-22 | Covalx Ag | Direct mass spectrometric analysis of drug candidates targeting protein complexes |
Family Cites Families (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2529213B1 (en) | 1982-06-24 | 1986-12-26 | Oreal | KERATIN DERIVATIVE, PREPARATION METHOD THEREOF AND TREATMENT COMPOSITION CONTAINING THE SAME |
JPH0791698B2 (en) | 1988-06-10 | 1995-10-04 | 帝人株式会社 | Pitch yarn carbon fiber manufacturing method |
JP2726274B2 (en) | 1988-08-24 | 1998-03-11 | 生化学工業株式会社 | Novel keratan sulfate degrading enzyme and microorganism and method for producing the same |
US5068315A (en) | 1990-04-12 | 1991-11-26 | University Of Dundee | Composition for the regulation of hair growth |
JPH0812530A (en) | 1994-06-28 | 1996-01-16 | Kao Corp | Hair growth-stimulating factor and hair growth-stimulating agent containing the same |
JP4194669B2 (en) | 1995-10-20 | 2008-12-10 | 花王株式会社 | Hair treatment agent |
US5910419A (en) | 1997-05-06 | 1999-06-08 | Johnson; Ted Donald | Method for forensically screening hair samples for the presence of cannabinoids |
JPH1171398A (en) | 1997-08-26 | 1999-03-16 | Seiwa Kasei:Kk | Hydrolyzed keratin having cystine introduced thereinto and its production |
US6462019B1 (en) | 1998-07-10 | 2002-10-08 | Osteoscreen, Inc. | Inhibitors of proteasomal activity and production for stimulating bone growth |
US6902721B1 (en) | 1998-07-10 | 2005-06-07 | Osteoscreen, Inc. | Inhibitors of proteasomal activity for stimulating bone growth |
DE19934242A1 (en) | 1999-07-21 | 2001-01-25 | Clariant Gmbh | Method for the detection of organic compounds on surfaces in humans |
KR100329962B1 (en) | 1999-10-01 | 2002-03-28 | 임병철 | a protease which degrades keratin layers of skin surface, a microorganism which produces the protease and a cosmetic composition containing a culture solution thereof. |
JP2001318096A (en) | 2000-05-10 | 2001-11-16 | Sumitomo Electric Ind Ltd | Screening method of substance having hair growth promoting effect |
GB0011269D0 (en) | 2000-05-11 | 2000-06-28 | Univ Sheffield | Protein over expression |
JP2001356125A (en) * | 2000-06-15 | 2001-12-26 | Kanebo Ltd | Evaluation method for hair damage |
CA2413449A1 (en) | 2000-06-28 | 2002-01-03 | Adelaide Research & Innovation Pty Ltd. | Altered wool and hair fibres |
US20090253125A9 (en) | 2001-03-05 | 2009-10-08 | Wangxia Wang | Denaturat stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same, their uses and methods of increasing a specific activity thereof |
US20050074763A1 (en) | 2001-03-05 | 2005-04-07 | Wangxia Wang | Denaturat stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same and their uses |
US7253341B2 (en) | 2001-03-05 | 2007-08-07 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Denaturant stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same, their uses and methods of increasing a specific activity thereof |
JP2003113200A (en) | 2001-10-01 | 2003-04-18 | Locomogene Inc | Intranuclear signal transduction protein of keratinocyte and its clinical application |
WO2003086313A2 (en) | 2002-04-12 | 2003-10-23 | Trustees Of Boston University | Methods for lightening skin and hair |
FR2847268B1 (en) | 2002-11-19 | 2006-09-29 | Coletica | METHOD FOR IDENTIFYING AN EVENTUALLY MODIFICATION OF AT LEAST ONE BIOLOGICAL PARAMETER USING LIVING CELLS SUBJECT TO STRESS AND LIVING CELLS NOT SUBJECT TO THIS SAME STRESS |
DE10260931B4 (en) | 2002-12-20 | 2006-06-01 | Henkel Kgaa | Method for determining the homeostasis of hairy skin |
JP4268073B2 (en) | 2003-03-04 | 2009-05-27 | 中野製薬株式会社 | Permanent wave forming ability diagnosis method, hair treatment agent, and hair treatment method |
CN1245420C (en) | 2003-03-19 | 2006-03-15 | 上海市计划生育科学研究所 | Systhesizing of chimeric peptide from anteron promoted by human's fine hair |
JP4370411B2 (en) | 2003-06-13 | 2009-11-25 | ライオン株式会社 | Hair growth agent, hair cosmetic for hair growth and pharmaceutical composition for hair growth |
JP2005110602A (en) | 2003-10-09 | 2005-04-28 | Sumitomo Pharmaceut Co Ltd | Disease marker of atopic dermatitis and utilization thereof |
FR2864539B1 (en) | 2003-12-30 | 2012-10-26 | Lvmh Rech | OLIGONUCLEOTIDE AND USE THEREOF FOR MODULATING THE EXPRESSION OF BETA-1 PROTEIN-KINASE C ISOFORM AS CUTANEOUS DEPIGMENTING AGENT |
WO2005077319A2 (en) | 2004-02-12 | 2005-08-25 | Unilever Plc | Hair treatment compositions comprising a protein disulfide isomerase |
EP1772225A4 (en) | 2004-07-29 | 2009-07-29 | Senju Metal Industry Co | Lead-free solder alloy |
EP1809651A4 (en) | 2004-10-21 | 2007-10-24 | Australian Wool Innovation Ltd | Method for separating keratinous proteins from materials |
US20060140893A1 (en) | 2004-12-14 | 2006-06-29 | L'oreal | Assay of hair proteins |
JP4669921B2 (en) | 2005-03-14 | 2011-04-13 | 信和化工株式会社 | Simple analysis method for drugs |
DE102005011957A1 (en) | 2005-03-14 | 2006-12-07 | Henkel Kgaa | New hair treatment composition containing L-carnitine or L-carnitine derivatives |
EP1930343A4 (en) | 2005-08-23 | 2009-05-13 | Seiwa Kasei Co Ltd | Method for preparation of reduced keratin, reduced cuticle protein or mixture thereof |
ITTO20050800A1 (en) | 2005-11-11 | 2007-05-12 | Univ Degli Studi Torino | USEFUL COMPOSITIONS FOR THE RECOVERY OF ORIGINAL TROFISM AND PIGMENTATION AND FOR THE STIMULATION OF THE GROWTH OF TEGUMENTARY EQUIPMENT, RELATED USES AND PRODUCTS |
WO2007062363A2 (en) | 2005-11-18 | 2007-05-31 | Large Scale Biology Corporation | Method for diagnosing a person having sjogren's syndrome |
CN101007847A (en) | 2006-01-23 | 2007-08-01 | 杭州北斗生物技术有限公司 | Human horny cell growth factor-2 mutant and its preparation method |
US9149566B2 (en) | 2006-02-17 | 2015-10-06 | Wake Forest University Health Sciences | Coatings and biomedical implants formed from keratin biomaterials |
US8273702B2 (en) | 2006-02-17 | 2012-09-25 | Wake Forest University Health Sciences | Wound healing compositions containing keratin biomaterials |
US20070249000A1 (en) | 2006-04-25 | 2007-10-25 | Daniel Tuse | Method for diagnosing a person having b-cell pathologies |
JP2008056579A (en) | 2006-08-30 | 2008-03-13 | Nakano Seiyaku Kk | Hair treatment preparation |
JP4824507B2 (en) | 2006-08-31 | 2011-11-30 | 中野製薬株式会社 | Straight perm agent |
DE102006042244A1 (en) | 2006-09-06 | 2008-03-27 | Henkel Kgaa | Method for the molecular characterization of senile hair |
WO2008055196A2 (en) | 2006-10-31 | 2008-05-08 | Genizon Biosciences Inc. | Genemap of the human genes associated with male pattern baldness |
EP2089532A4 (en) | 2006-12-01 | 2010-02-17 | Cedars Sinai Medical Center | Positive selection of serum proteins for proteomic analysis |
DE102006060154A1 (en) | 2006-12-18 | 2008-06-19 | Henkel Kgaa | Method for the molecular characterization of gray and pigmented hair |
FR2911778B1 (en) | 2007-01-29 | 2009-07-10 | Oreal | METHOD FOR DETECTING A DETECTING DETECTING DETECTION OF AN ALKALI AGENT |
JP2008232674A (en) * | 2007-03-16 | 2008-10-02 | National Research Institute Of Police Science Japan | Method for extracting and analyzing chemical substance accumulated in hair |
CN101054579A (en) | 2007-03-29 | 2007-10-17 | 上海复旦新杨生物科技有限责任公司 | A siRNA capable of preventing and curing hair loss and accelerating hair growth, and preparation method and application thereof |
JP4881818B2 (en) | 2007-08-31 | 2012-02-22 | 中野製薬株式会社 | Permanent wave processing method |
JP2009096774A (en) | 2007-10-19 | 2009-05-07 | Nakano Seiyaku Kk | Permanent wave first agent |
EP2212442A1 (en) | 2007-10-26 | 2010-08-04 | Galderma Research & Development | Non-invasive method to perform skin inflammatory disease pharmaco-genomic studies and diagnosis method thereof |
JP2009107977A (en) | 2007-10-31 | 2009-05-21 | Nakano Seiyaku Kk | Cosmetic |
CN101458238B (en) | 2008-08-19 | 2012-01-04 | 上海市徐汇区中心医院 | Method for detecting Clenbuterol residual quantity in hair |
JP2010112788A (en) * | 2008-11-05 | 2010-05-20 | Shiseido Co Ltd | Method of evaluating hair quality |
CN101457218A (en) | 2008-12-12 | 2009-06-17 | 山东大学 | Polylactic acid degrading enzyme with protein degrading activity |
CA2798517C (en) | 2010-05-17 | 2016-07-05 | The Procter & Gamble Company | Systems and methods of detecting and demonstrating hair damage via evaluation of protein fragments |
US20110281366A1 (en) | 2010-05-17 | 2011-11-17 | Michael Glenn Davis | Systems and Methods of Detecting and Demonstrating Hair Damage Via Detection of Protein Loss |
CN104093394A (en) | 2012-01-09 | 2014-10-08 | 宝洁公司 | Hair care compositions |
-
2011
- 2011-05-17 CA CA2798517A patent/CA2798517C/en not_active Expired - Fee Related
- 2011-05-17 US US13/109,546 patent/US20110281256A1/en not_active Abandoned
- 2011-05-17 JP JP2013510366A patent/JP5513679B2/en active Active
- 2011-05-17 WO PCT/US2011/036782 patent/WO2011146462A1/en active Application Filing
- 2011-05-17 EP EP11721690.3A patent/EP2572201B1/en active Active
- 2011-05-17 CN CN201180024698.5A patent/CN102893160B/en active Active
-
2014
- 2014-03-18 US US14/217,977 patent/US9310351B2/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100099200A1 (en) * | 2007-03-16 | 2010-04-22 | Covalx Ag | Direct mass spectrometric analysis of drug candidates targeting protein complexes |
Non-Patent Citations (2)
Title |
---|
A Simple and Sensitive Technique, Based on Protein Loss Measurements, to Assess Surface Damage to Human Hair Sukhvinder S. Sandhu and Clarence R. Robbins J. Soc. Cosmet. Chem., 44, 163-175 (May/June 1993) * |
MALDI MS in Analysis of Keratin Fibre Proteins Andrea Korner Springer Science + Business Media B.V. 2008 * |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9310351B2 (en) | 2010-05-17 | 2016-04-12 | The Procter & Gamble Company | Systems and methods of detecting and demonstrating hair damage via evaluation of protein fragments |
US9671410B2 (en) | 2011-01-16 | 2017-06-06 | The Procter & Gamble Company | Biomarker-based methods for identifying and formulating compositions that improve skin quality and reduce the visible signs of aging in skin |
US20150364312A1 (en) * | 2014-06-12 | 2015-12-17 | The Procter & Gamble Company | Systems and Methods Of Detecting and Demonstrating Heat Damage to Hair Via Evaluation of Peptides |
WO2015191344A1 (en) * | 2014-06-12 | 2015-12-17 | The Procter & Gamble Company | Method of detecting and demonstrating heat damage to hair via evaluation of peptides |
US20150362507A1 (en) * | 2014-06-12 | 2015-12-17 | The Procter & Gamble Company | System and Methods of Detecting and Demonstrating Ultraviolet Damage to Hair Via Evaluation of Protein Fragments |
US9748085B2 (en) * | 2014-06-12 | 2017-08-29 | The Proctor & Gamble Company | Systems and methods of detecting and demonstrating heat damage to hair via evaluation of peptides |
US10966916B2 (en) | 2014-11-10 | 2021-04-06 | The Procter And Gamble Company | Personal care compositions |
US11207261B2 (en) | 2014-11-10 | 2021-12-28 | The Procter And Gamble Company | Personal care compositions with two benefit phases |
US11207248B2 (en) | 2014-11-10 | 2021-12-28 | The Procter And Gamble Company | Personal care compositions with two benefit phases |
US10987290B2 (en) | 2017-10-20 | 2021-04-27 | The Procter And Gamble Company | Aerosol foam skin cleanser |
US11419805B2 (en) | 2017-10-20 | 2022-08-23 | The Procter & Gamble Company | Aerosol foam skin cleanser |
US11365397B2 (en) | 2018-11-29 | 2022-06-21 | The Procter & Gamble Company | Methods for screening personal care products |
CN113125546A (en) * | 2020-11-06 | 2021-07-16 | 郑州安图生物工程股份有限公司 | Hair mass spectrum detection chip and hair rapid identification method |
Also Published As
Publication number | Publication date |
---|---|
JP5513679B2 (en) | 2014-06-04 |
US9310351B2 (en) | 2016-04-12 |
US20140197309A1 (en) | 2014-07-17 |
EP2572201A1 (en) | 2013-03-27 |
CA2798517A1 (en) | 2011-11-24 |
CN102893160B (en) | 2015-10-14 |
WO2011146462A1 (en) | 2011-11-24 |
EP2572201B1 (en) | 2015-08-26 |
JP2013526712A (en) | 2013-06-24 |
CA2798517C (en) | 2016-07-05 |
CN102893160A (en) | 2013-01-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9310351B2 (en) | Systems and methods of detecting and demonstrating hair damage via evaluation of protein fragments | |
van Doorn et al. | A novel and non-destructive approach for ZooMS analysis: ammonium bicarbonate buffer extraction | |
Hale et al. | Increased sensitivity of tryptic peptide detection by MALDI-TOF mass spectrometry is achieved by conversion of lysine to homoarginine | |
Gevaert et al. | Protein identification based on matrix assisted laser desorption/ionization‐post source decay‐mass spectrometry | |
Carrera et al. | Extensive de novo sequencing of new parvalbumin isoforms using a novel combination of bottom-up proteomics, accurate molecular mass measurement by FTICR− MS, and selected MS/MS Ion monitoring | |
Marekov et al. | Charge derivatization by 4‐sulfophenyl isothiocyanate enhances peptide sequencing by post‐source decay matrix‐assisted laser desorption/ionization time‐of‐flight mass spectrometry | |
Koehn et al. | The proteome of the wool cuticle | |
US20060141632A1 (en) | New methods and kits for sequencing polypeptides | |
Soderblom et al. | Tandem mass spectrometry acquisition approaches to enhance identification of protein‐protein interactions using low‐energy collision‐induced dissociative chemical crosslinking reagents | |
Marsh et al. | Advanced hair damage model from ultra‐violet radiation in the presence of copper | |
Leon et al. | Improved protein identification efficiency by mass spectrometry using N‐terminal chemical derivatization of peptides from Angiostrongylus costaricensis, a nematode with unknown genome | |
Cleland et al. | Diagenetiforms: a new term to explain protein changes as a result of diagenesis in paleoproteomics | |
WO2017053792A1 (en) | Method for determining the in vivo comparability of biologic drug and a reference drug | |
CA2359163C (en) | Methods and kits for sequencing polypeptides | |
Sharov et al. | Two-dimensional separation of the membrane protein sarcoplasmic reticulum Ca–ATPase for high-performance liquid chromatography–tandem mass spectrometry analysis of posttranslational protein modifications | |
Longuespée et al. | Spectroimmunohistochemistry: a novel form of MALDI mass spectrometry imaging coupled to immunohistochemistry for tracking antibodies | |
Napoli et al. | Profiling of hydrophilic proteins from Olea europaea olive pollen by MALDI TOF mass spectrometry | |
Yew et al. | De novo sequencing of novel neuropeptides directly from Ascaris suum tissue using matrix‐assisted laser desorption/ionization time‐of‐flight/time‐of‐flight | |
Taylor et al. | Mass spectrometric profiling of O‐linked glycans released directly from glycoproteins in gels using in‐gel reductive β‐elimination | |
US20050176085A1 (en) | Method of selective peptide isolation for the identification and quantitative analysis of proteins in complex mixtures | |
JP2017524897A (en) | System and method for detecting and indicating UV damage to hair by evaluating protein fragments | |
Noort et al. | Modification of human serum albumin by acrylamide at cysteine-34: a basis for a rapid biomonitoring procedure | |
EP1133697B1 (en) | Method for modifying and identifying functional sites in proteins | |
US9748085B2 (en) | Systems and methods of detecting and demonstrating heat damage to hair via evaluation of peptides | |
Pasini et al. | Extraction and mass spectrometry identification of a major peach allergen Pru p 1 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: THE PROCTER & GAMBLE COMPANY, OHIO Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:DAVIS, MICHAEL GLENN;FLAGLER, MICHAEL JOSEPH;SUN, YIPING;AND OTHERS;REEL/FRAME:027290/0546 Effective date: 20110517 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |